Effect of Different Local Anesthetic Volumes of Serratus Anterior Plan Block After Video-Assisted Thoracoscopic Surgery

Launched by ATATÜRK CHEST DISEASES AND CHEST SURGERY TRAINING AND RESEARCH HOSPITAL · Feb 15, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how different amounts of a local anesthetic (specifically, bupivacaine) can help manage pain after a type of surgery called video-assisted thoracoscopic surgery (VATS). The researchers want to find out whether using 20 ml or 30 ml of the anesthetic will be more effective in reducing pain for patients after their surgery. This study is important because managing pain after surgery can greatly improve recovery and comfort for patients.

To be eligible for this trial, participants should be between 18 and 65 years old and scheduled for an elective VATS surgery. They should also have a body mass index (BMI) between 18 and 30 and be in good overall health (ASA physical status I-II-III). Patients who are taking chronic pain medications or need emergency surgery will not be able to participate. If you join this trial, you can expect to receive either the 20 ml or 30 ml dose of the anesthetic during your surgery, and the researchers will monitor your pain levels afterward to see which dose works better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 to 65 years old
• • ASA physical status I-II-III
• • BMI 18 to 30 kg/m2
• • Elective video assisted thoracoscopic surgery
• Exclusion Criteria:
• • Patient refusing the procedure
• • Emergency surgery
• • Chronic opioid or analgesic use